Whether we like it or not, putting politics aside, the reality is, China has a fairly sizable population. And therefore a pretty large TAM (total addressable market).
As such, it probably is better to have some Patents protection rather than none. Hence, I take it as a positive development for onCARlytics
kluck
Ann: Oncolytic Virotherapy CF33 Patent Granted in China, page-51
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
